Microbix Biosystems Inc (MBXBF)

[yielddude]

From yesterday's PR ...

At present, Microbix has capacity to make 5,000 units per week of room-temperature stable COVID-19 QAPs exclusively on COPAN® FLOQSwabs®, and 10,000 units per week in a liquid vial format. Such QAPs can be shipped as early as April 30 to support the verification of new testing methods, the validation of newly-placed test instruments, training of technicians, lab proficiency accreditations, and by clinical labs for systematic quality control. By way of example, at usage of one per hundred tests, such QAPs can help ensure the accuracy of 1.5 million COVID-19 tests per week.


So they have the current capacity to make 15K/week, but no, I don't know if they will sell that many. I believe they can, as the current demand for testing is more than 1.5M patient tests per week. Also, there is a current shortage of the swabs, so they should easily be able to supply those 5K/week. I am not as familiar with the liquid vial format, but from everything I have been reading, there is a huge demand for testing.

Here is a snip from one NT Times article ...
An average of 146,000 people per day have been tested for the coronavirus nationally so far this month, according to the COVID Tracking Project, which on Friday reported 3.6 million total tests across the country. To reopen the United States by mid-May, the number of daily tests performed between now and then should be 500,000 to 700,000, according to the Harvard estimates.
https://www.nytimes.com/interactive/2020/04/17/us/coronavirus-testing-states.html

And that is just the United States. Worldwide, it is going to be multiples of that.

Regards,
yield